摘要
目的:评价血清CA125在恶性肿瘤诊断中的价值。方法:回顾性分析2775例不同疾病患者的血清CA125结果(临界值35U/ml)。结果:胆囊癌、胰腺癌、卵巢癌、肺癌和肝癌患者的血清CA125阳性率较其它肿瘤患者高(P<0.05)。在一些严重的非肿瘤疾病如器官衰竭、肝硬化、肺结核等也有较高的阳性率。患同样的疾病,有腹水的患者血清CA125水平较没有腹水者高(P<0.05)。结论:血清CA125水平对于胆囊癌胰腺癌、卵巢癌、肺癌和肝癌等恶性肿瘤的辅助诊断有一定的临床应用价值,但应注意与肝硬化,肺结核等非肿瘤疾病的鉴别诊断。
Objective：To assess the diagnosis value of serum CA125 in carcinoma. Methods： The results of serum CA125 of 2775 patients were studied. Results： The positive rates of serum CA125 in patients with gall hladder cancer, pancreas cancer, ovarian cancer, lung cancer and liver cancer are higher than that in patients with other carcinoma （ P 〈 0.05 ）. In some serious non - carcinoma diseases, such as organ failure, cirrhosis of liver, tuberculosis with effusion etc. also had very high positive rate of serum CA125. With same disease, the serum CA125 level in patients with effusion was higher than that without effusion （P 〈 0.05 ）. Conclusion： Serum CA125 level is helpful for the diagnosis of gall hladder cancer, pancreas cancer, ovarian cancer, lung cancer and liver cancer. But attention should be paid to distinguishing them from cirrhosis and tuberculosis.
出处
《现代肿瘤医学》
CAS
2006年第12期1603-1604,共2页
Journal of Modern Oncology
